Filing Flows › OneMedNet (ONMD) › R&D spending
OneMedNet (ONMD) R&D spending by quarter
OneMedNet's R&D spending was $324K in Q2 2026 (second quarter 2026), +4% from Q1 2026. Over the last 7 quarters it ranged from $311K (Q1 2026) to $443K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $324K | +4% | -15% |
| Q1 2026 | $311K | -30% | -11% |
| Q4 2025 | $443K | +37% | +30% |
| Q3 2025 | $323K | -15% | — |
| Q2 2025 | $382K | +10% | — |
| Q1 2025 | $348K | +2% | — |
| Q4 2024 | $340K | — | — |
Q2 2026 at a glance
OneMedNet, Q2 2026: revenue $292K (+88% year over year), operating margin -774.3%, net loss $2.2M, operating cash flow −$1.9M. The chart follows the revenue to costs, profit and cash.
Questions
What is OneMedNet's R&D spending?
OneMedNet's R&D spending was $324K in Q2 2026 (second quarter 2026), +4% from Q1 2026.
How has OneMedNet's R&D spending changed?
Over the last 7 quarters it ranged from $311K (Q1 2026) to $443K (Q4 2025).